关注
Zobair Younossi
Zobair Younossi
其他姓名Zobair M. Younossi
The Global NASH Council
在 cldq.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Global epidemiology of nonalcoholic fatty liver disease—meta‐analytic assessment of prevalence, incidence, and outcomes
ZM Younossi, AB Koenig, D Abdelatif, Y Fazel, L Henry, M Wymer
Hepatology 64 (1), 73-84, 2016
104722016
The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases
N Chalasani, Z Younossi, JE Lavine, M Charlton, K Cusi, M Rinella, ...
Hepatology 67 (1), 328-357, 2018
65652018
The diagnosis and management of non‐alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of …
N Chalasani, Z Younossi, JE Lavine, AM Diehl, EM Brunt, K Cusi, ...
Hepatology 55 (6), 2005-2023, 2012
50792012
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Z Younossi, QM Anstee, M Marietti, T Hardy, L Henry, M Eslam, J George, ...
Nature reviews Gastroenterology & hepatology 15 (1), 11-20, 2018
47092018
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity
CA Matteoni, ZM Younossi, T Gramlich, N Boparai, YC Liu, ...
Gastroenterology 116 (6), 1413-1419, 1999
44331999
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
G Vernon, A Baranova, ZM Younossi
Alimentary pharmacology & therapeutics 34 (3), 274-285, 2011
40952011
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
M Eslam, AJ Sanyal, J George, A Sanyal, B Neuschwander-Tetri, ...
Gastroenterology 158 (7), 1999-2014. e1, 2020
26022020
The utility of radiological imaging in nonalcoholic fatty liver disease
S Saadeh, ZM Younossi, EM Remer, T Gramlich, JP Ong, M Hurley, ...
Gastroenterology 123 (3), 745-750, 2002
24962002
Sofosbuvir for previously untreated chronic hepatitis C infection
E Lawitz, A Mangia, D Wyles, M Rodriguez-Torres, T Hassanein, ...
New England Journal of Medicine 368 (20), 1878-1887, 2013
24202013
The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of …
N Chalasani, Z Younossi, JE Lavine, AM Diehl, EM Brunt, K Cusi, ...
Gastroenterology 142 (7), 1592-1609, 2012
21252012
Telaprevir for retreatment of HCV infection
S Zeuzem, P Andreone, S Pol, E Lawitz, M Diago, S Roberts, R Focaccia, ...
New England Journal of Medicine 364 (25), 2417-2428, 2011
21162011
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
C Estes, H Razavi, R Loomba, Z Younossi, AJ Sanyal
Hepatology 67 (1), 123-133, 2018
20902018
Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States
RJ Wong, M Aguilar, R Cheung, RB Perumpail, SA Harrison, ...
Gastroenterology 148 (3), 547-555, 2015
20422015
Non-alcoholic fatty liver disease–a global public health perspective
ZM Younossi
Journal of hepatology 70 (3), 531-544, 2019
18822019
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis
ZM Younossi, P Golabi, L de Avila, JM Paik, M Srishord, N Fukui, Y Qiu, ...
Journal of hepatology 71 (4), 793-801, 2019
17662019
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta‐analysis
PS Dulai, S Singh, J Patel, M Soni, LJ Prokop, Z Younossi, G Sebastiani, ...
Hepatology 65 (5), 1557-1565, 2017
17052017
Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Z Younossi, F Tacke, M Arrese, B Chander Sharma, I Mostafa, ...
Hepatology 69 (6), 2672-2682, 2019
16542019
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, ...
Hepatology 78 (6), 1966-1986, 2023
15132023
Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008
ZM Younossi, M Stepanova, M Afendy, Y Fang, Y Younossi, H Mir, ...
Clinical gastroenterology and hepatology 9 (6), 524-530. e1, 2011
14372011
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
ZM Younossi, D Blissett, R Blissett, L Henry, M Stepanova, Y Younossi, ...
Hepatology 64 (5), 1577-1586, 2016
12732016
系统目前无法执行此操作,请稍后再试。
文章 1–20